Actively Recruiting
Prognostic Impact of Lesion-specific Hemodynamic Index in Patients With Coronary Artery Disease
Led by Seoul National University Hospital · Updated on 2022-02-22
2429
Participants Needed
1
Research Sites
282 weeks
Total Duration
On this page
Sponsors
S
Seoul National University Hospital
Lead Sponsor
K
Keimyung University Dongsan Medical Center
Collaborating Sponsor
AI-Summary
What this Trial Is About
The investigators aim to investigate the additive prognostic value of lesion-specific hemodynamic index such as ΔFFR, non-hyperemic pressure ratio such as RFR, over % diameter stenosis and FFR according to treatment strategy, and to find the prognostic implications of post-PCI FFR after adjustment of various clinical and disease characteristics, and to construct a comprehensive risk prediction model for post-PCI outcomes.
CONDITIONS
Official Title
Prognostic Impact of Lesion-specific Hemodynamic Index in Patients With Coronary Artery Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age �3E=20 years
- Successfully underwent fractional flow reserve (FFR) measurement and pullback tracing
You will not qualify if you...
- Chronic renal failure with estimated glomerular filtration rate less than 30
- ST-elevation myocardial infarction within 72 hours or history of coronary artery bypass graft surgery
- Primary myocardial or valvular disease
- Left ventricular ejection fraction less than 30%
- Hemodynamically unstable clinical conditions
- Life expectancy less than 2 years
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Seoul National University Hospital
Seoul, South Korea, 110-744
Actively Recruiting
Research Team
B
Bon-Kwon Koo, MD, PhD
CONTACT
S
Seokhun Yang, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here